Tag Archives: information

Baby Cured of HIV – Here’s the real message..

caduceus-and-red

Late Sunday night, the world media started to report about a baby, born with HIV had been cured.  Everybody got talking; scientists, people of faith, doctors, the public, HIV experts, me, you!

It’s easy to get caught up in the excitement of a cure, I honestly didn’t think I’d be writing the phrase ‘HIV Cure’ for at least a few more years yet, but as it were, we were given a flurry of media reports about how this case was set to change the HIV treatment paradigm, prevent babies from being infected, and, to quote the principal author of the study, Dr Deborah Persaud, “transform our current treatment practices in newborns worldwide”.

There are reports that parents and guardians are asking if this means that children who are infected at birth can stop their drugs.  People are very over-optimistic, and have been calling their doctors and specialists raising the question of whether they, or their child could also be cured!

More Data Needed

We need to slow down, and get some perspective.  The news was only announced five days ago.

To quote a famous professor of HIV pharmacology: “We need more data.” We need to take stock, get the facts right, and allow for scrutiny of the case by the scientific community.

There are many questions to be asked of the case. For instance, was the baby truly infected in the first place? From reviewing the data presented at the conference, it certainly seems possible. But how established was this infection? Had it established itself in so-called long-lived memory T cells?

Furthermore, when was the actual point of infection? This is not clear. Could it have been just prior to delivery? If so, it is possible that by serendipity the doctors intervened with drugs just as the virus was trying to become established.

A Cure, or PEP?

It’s imperative, then, that we attempt to understand when exactly this baby was infected. Was it just before birth, or several months before birth? The longer the period of time, the more interesting the case becomes.

However, if the intervention simply aborted the establishment of infection then Dr Persaud’s results are less exciting.

If drugs were introduced very shortly after infection, the treatment may have actually acted as PEP (post-exposure prophylaxis) – a strategy already used by HIV doctors to try and avoid establishment of infection

Think of a fire which has just caught alight, but has yet really to take hold. Pouring a bucket of water on it at this point may kill the fire dead. Was there actually a flame, or the presence of detectable virus, in this case? Yes, of course. But this bucket of water may not have worked had you allowed the ‘fire’ to become properly established.

The case being described by many as a ‘cure’ may in fact be like this bucket of water – effective, but only because it was delivered so early.

Taking the fire analogy further, after we have put out the flames we may still see the residues it left behind. It might even reignite at a later point in time. The Mississippi baby has been off anti-retroviral drug treatment [ARVs] for less than a year – there are currently no flames, but we are waiting to see if the embers are truly burned out.

Currently, and beyond this headline case, we have no way to completely put out the fire of HIV once it has caught hold. Our current ARV treatments, then, are the firemen who keep the flames of HIV at bay. As long as they are there, you can begin to rebuild the house – a fact born out by the fact that hundreds of thousands of our patients have been on totally suppressive regimens for up to twenty years.

Currently, it is a truth that, if you stop therapy, the virus inevitably rebounds when you –cease medication usually within two weeks. Admittedly, there are a very few rare cases where the virus may simply smoulder away at very low levels for many years (so-called “post treatment controllers”).

All of these considerations and unanswered questions mean that we have a long way to go yet before we fully understand this case. We must fully explore the baby’s immune make-up. What about the characteristics of the mother’s virus, which was curiously low for someone not on treatment? There are so many questions before we should really call this a cure.

Other than the potential of Dr Persaud’s research to stimulate further investigations, then, what is the best thing that can come of all this media frenzy?

The great hope is that this moment represents the greatest mass HIV awareness campaign since the Don’t Die of Ignorance ‘tombstone’ campaign of the 1980s. Rarely does HIV make such headlines, and we have a real chance to educate people whilst their interest is piqued.

We must tell people that the story of HIV is very different now, and we must take this opportunity to communicate new messages through the media whose attention we currently have – messages which can correct people’s out-dated misconceptions.

  • Let’s talk about testing, and the importance of early diagnosis.
  • Let’s talk about effective drugs, which when prescribed early enough can help a patient live a long and full life.
  • Let’s talk about condoms and prevention.
  • Let’s tackle stigma!

Today there is no reason for any baby to be become HIV positive, if the mother is tested and diagnosed early in pregnancy – and if she and the baby have access to effective treatments which can prevent transmission. Sadly, 590,000 babies every year are still born HIV-positive in the developing world: an unnecessary tragedy.

We can do something about that right now, with the tools we have – If we increase testing and make it more regular and consistent. In the UK, 95% of women take the HIV tests during pregnancy. And with effective treatment the chance of the baby being born positive is less than 0.5%. We should be aiming for the same success all over the world

Above and beyond a media storm about a supposed ‘cure’, there are good news stories we can make happen today.

Is the ‘cure’ story exciting? Yes. Is it scientifically plausible? Yes. Will it stimulate more research? Almost certainly. But it is extremely premature to hail it as a cure that will translate into routine clinical care any time soon. We need much more data.

So if you or your child are HIV-positive, then please… don’t stop taking your tablets. And if you have had unprotected sex, take the test. Condoms, education, testing, and access to treatment are our real weapons against HIV, and we need to learn to use these correctly if we want to make a real impact today.

When was your last HIV test?

We offer offer a completely free and confidential rapid HIV test (results within 60 seconds from a simple finger prick test)!  We use the Insti HIV test produced by BioLytical laboratories. The test is 99.96% accurate from 90 days after  contact for detecting HIV 1 and 2 antibodies.  We also have a mobile testing van which is often out in communities providing mobile rapid HIV tests. Appointments are not necessary, call us (0116 2559995) we’re here to help.

 STAY UPDATED
Follow LASS on Twitter
or subscribe via email

YOU MAY ALSO BE INTERESTED IN..

Leicestershire Community Calendar 2012

LASS’s Social Enterprise Well For Living launched a new initiative to help raise funds and awareness for Community Organisations and Charities.

Twelve different organisations, came together and developed a Community Calendar designed to encourage community involvement and help raise funds in this difficult climate.   The calendar also highlights important dates for the sector, such as Volunteers Week.

All Charities featured work to improve the lives of people living in Leicester and Leicestershire, and all are featured together in a calendar to display their good work throughput the year.

Read more about it at Well For Living.  http://www.wellforliving.co.uk/

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

Consultation To Start On Managing Urgent Care In Loughborough

Members of the public are being invited to have their say on the Walk-In Centre and the future of urgent care in Loughborough and surrounding areas.

West Leicestershire Clinical Commissioning Group (WLCCG), which will be responsible for commissioning or ‘buying’ local healthcare from April 2013, has been looking at urgent care services locally and how they are provided.

The CCG wants to ensure that when people need urgent care they can receive it as effectively as possible, whilst looking to work with other parts of the NHS to ensure that local services such as the community hospital are as effective as possible in bringing care closer to home.

As part of this a 12-week public consultation started last Wednesday (19 October) [Ed: We only received this news today, sorry for the delay], which offers two options:

· Option one is urgent care at the current Walk-In Centre at Pinfold Gate

· Option two is urgent care provided at Loughborough Hospital in Epinal Way

Option two is the preferred option as the hospital, which is 1.6 miles from Pinfold Gate, can provide more access to diagnostic tests, including more extended access to x-rays, potential access to ultrasound scans and blood tests. There are also beds where there is potential for patients to be kept in for observation and further potential for access to clinicians already working in the hospital.

Dr Nick Willmott, a GP and chairman of the group planning the development of urgent care in West Leicestershire, said: “This consultation is about enhancing services and making sure that patients receive the best care in the most appropriate setting for their health needs.

“We believe that our plans will provide an enhanced service for those who need urgent care, whilst we continue to encourage people to see their GPs when possible for less urgent needs.  Moving the Walk-In Centre could bring care closer to home for many patients accessing the urgent care service and could mean they wouldn’t have to travel into Leicester. It would also avoid duplication of services locally.”

Dr Edward Clode-Baker, of Parkview Surgery, added:

“GPs want, wherever possible, to be the first port of call if you’re in doubt about what care you need. We are doing all we can to improve access both to telephone advice and seeing patients appropriately. This will free up services at the Walk-In Centre to treat those with urgent need.”

The project group developing the proposals included GPs, a representative of Leicestershire Local Involvement Network (LINk), a patient representative, and officers of the West Leicestershire CCG. Feedback has also been received from staff at the Walk-In Centre, local government colleagues and the local MP. Leicestershire LINk has been involved in the consultation process and the engagement event held in August, and will be monitoring developments closely on behalf of patients and the public.

NHS West Midlands Clinical Commissioning Group have produced a document: “Loughborough Walk-In Centre, Managing Urgent Care In Loughborough – A Public Consultation” (pdf).  This document gives you the background to their public consultation about the Walk-In Centre and urgent care in Loughborough.

The Walk-In Centre provides urgent care services in Pinfold Gate for people living in or near Loughborough. they have proposals about how people can receive these services in future, and we need to understand what local people think about these proposals. They propose to create an urgent care centre
at Loughborough Hospital which will be supported by all the services available at
that centre. We believe this will produce an enhanced service for the local population with the coming together of the professional expertise and diagnostic services that can be provided by Loughborough Hospital. This can only be achieved by the movement of the Walk-In Centre and the resources that
support it.

Please take a few moments to read through the document, and then to answer the questions at the end.  The information and questionnaire are also
available online, at http://www.lcr.nhs.uk

During the consultation people will be able to have their say in a questionnaire which will be available from the Walk-In Centre, local libraries, GP surgeries and council buildings, as well as online by visiting http://www.lcr.nhs.uk before 11 January 2012. It will also be available to fill in at a series of public meetings, which take place on:

For more information, or to request a questionnaire via post, please call Jo Lilley on 0116 295 7626 or email jo.lilley@lcr.nhs.uk

STAY UPDATED
or subscribe via email

Leicestershire Community Calendar 2012

LASS’s Social Enterprise Well For Living launched a new initiative to help raise funds and awareness for Community Organisations and Charities.

Twelve different organisations, came together and developed a Community Calendar designed to encourage community involvement and help raise funds in this difficult climate.   The calendar also highlights important dates for the sector, such as Volunteers Week.

All Charities featured work to improve the lives of people living in Leicester and Leicestershire, and all are featured together in a calendar to display their good work throughput the year.

Read more about it at Well For Living.  http://www.wellforliving.co.uk/

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

HIV Diagnosis Progress Hampered by Inaccurate Online Information

Inaccurate and out-of-date online information about HIV is hampering efforts to improve early diagnosis rates, the National Aids Trust (NAT) has warned.

National AIDS Trust have set up HIVaware.org.uk, run in partnership with Durex.The charity carried out an audit of websites featuring information on HIV and other sexual health issues and found that much information was incorrect or out of date.

NAT chief executive Deborah Jack told GPonline.com that information about symptoms in particular was often inaccurate and represented a ‘missed opportunity’ to improve early diagnosis rates.

‘Given that we know that the majority of new infections are from people who are themselves undiagnosed – many of them at an early stage of infection – this is a real missed opportunity to educate people,’ she said.

‘There is no information about what the most common symptoms are what someone should do if they experience symptoms after putting themselves at risk.’

She said websites often stated that many people have no symptoms of HIV infection for years, even though 70%-90% of people have some symptoms during sero-conversion.

HIVaware.org.uk, will also be contacting publishers of inaccurate online information ‘to identify the content that needs updating and make suggestions as to how it can be improved’.

Ms Jack said the most common area where information was out of date is around testing. A number of sites state that laboratories can only test for HIV antibodies, whereas they can now test for antigens and nearly all clinics use these tests, she said.

Websites also inaccurately stated that there is no point in taking a test for at least three months and that patients need to wait for your test to be sent off to a laboratory to get your results, she said. In fact, antigen tests provide accurate results from four weeks after potential infection and point of care tests, which provide results in 20 minutes, are now being used in a number of settings.

Original Article by Tom Moberly at GPOnline.com

Are you interested in having a HIV test?  We offer a completely free and confidential rapid HIV test and you’ll get the results within 60 seconds from a simple finger prick test. We use the Insti HIV test produced by BioLytical laboratories. The test is 99.96% accurate from 90 days post contact for detecting HIV 1 and 2 antibodies. We also have a mobile testing van which is often out in communities providing mobile rapid HIV tests. Appointments are not always necessary, if you would like a test, please contact us on 0116 2559995

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

Antiretroviral Drugs Work – This Is Why You Should Take Them!

In light of yesterday’s news which reported that three people died after they stopped taking antiretroviral medicine on the advice of a religious leader, it’s important to highlight why anti-HIV drugs are significant and how essential it is to take them correctly.

HIV is a virus which attacks the immune system – the body’s defence system against infection and illness. If you have HIV, you can take drugs to reduce the level of HIV in your body. By reducing the amount of HIV in your body, you can slow or prevent damage to your immune system. These drugs are not a cure, but they can help you stay well and extend your life. Anti-HIV drugs are known as antiretroviral drugs.

HIV mainly infects cells in the immune system called CD4 cells. Over many years of HIV infection, the number of CD4 cells drops gradually but continually and the immune system is weakened. If nothing is done to slow or halt this destruction of the immune system, a condition called AIDS (Acquired Immune Deficiency Syndrome) follows, as the immune system is no longer able to fight infections. Antiretroviral drugs work by interrupting this process.

An untreated person with HIV may have thousands or even millions of HIV particles in every millilitre of blood. The aim of treatment is to reduce the amount of HIV to very low levels (this is called an ‘undetectable’ level) – below 50 copies per millilitre of blood, although some HIV treatment centres are now using tests that can measure as low as 40 copies/ml.

To provide you with the best chance of reducing the amount of HIV in your blood to very low levels, your doctor will recommend that you take a powerful combination of at least three antiretroviral drugs. Once your viral load – the amount of HIV in your blood – has dropped, your immune system should begin to recover and your ability to fight infections is likely to improve.

When you start or change a drug combination, a viral load and CD4 count will be done within the first month of treatment. This is to check that the drugs are working. Testing is generally performed every three months, although some doctors may perform tests more often to begin with and less frequently once you are well established on treatment and doing well.

Once you are on HIV treatment, you may have tests to measure liver and kidney function and fat and sugar levels in your blood, to assess the effects of the drugs on the normal workings of your body.

Your HIV care will also involve a number of other routine tests. These will be to monitor your general health and to see if your treatment is causing any side-effects.

It is very important not to miss doses of your anti-HIV drugs and to take them exactly as prescribed. If you miss doses, or you do not take the drugs as you are supposed to, the HIV in your body is more likely to develop resistance to them. This will reduce their long-term effectiveness.

The above information is taken from NAM’s “Anti-HIV Drugs” booklet which you can download from here, (or pick up a copy from LASS, next time you’re in)  Additionally, Uptodate.com has very useful information and tips for taking HIV meds, it’s always a good idea to refresh your knowledge on Adherence.

Having a daily timetable for taking medication and taking all doses exactly as prescribed is the traditional definition of adherence, also known as compliance. This may sound simple, but in the case of highly active antiretroviral treatment (HAART), it is not. The challenge only increases as people who are infected and able to access therapy face life-long treatment and side-effect management.

If some medications are not taken at the correct time interval, the drug level can either be too high (causing unnecessary toxicities or side-effects) or too low (encouraging viral resistance). From a public health standpoint, suboptimal adherence also increases both the risk of transmission and the risk of transmitting drug-resistant virus to others.

Correctly taken, highly active antiretroviral therapy (HAART) maintains a consistent attack on HIV. When drug levels in the body fluctuate, HIV is given the opportunity to reproduce. Ongoing replication permits drug-resistant viral strains to develop and this narrows future treatment options.

Beyond personal benefit, maintaining adherence and viral suppression has a public health benefit. When viral load is low, so is the likelihood of transmission to others.

For more details on adherence or HIV medicines, speak with your doctor and health care professionals.

Philadelphia FIGHT (Field Initiating Group for HIV Trials) is a comprehensive AIDS service organization providing education, advocacy and research on potential treatments and vaccines. FIGHT was formed as a partnership of individuals living with HIV/AIDS and clinicians, who joined together to improve the lives of people living with HIV. They produce educational videos via “The AIDS Library” and serves the community through delivery of information on HIV, such as treatments, nutrition, and history of the pandemic, and referrals to regional and national resources.

The following videos are a 30 minute presentation on How HIV Meds work,

How HIV Meds Work Part 1: HIV Life Cycle

How HIV Meds Work Part 2: Drug Classes

How HIV Meds Work Part 3: Timing

Source material for this article via NAM, BBC News, Uptodate.com, Avert.com, Bupa and Philadelphia FIGHT

STAY UPDATED
or subscribe via email
 

Criminal Prosecutions – Useful Information

Since 2001, people living with HIV in the UK have been prosecuted for the reckless transmission of HIV. There are real concerns that these prosecutions are undermining efforts to stop the spread of HIV in the UK and are increasing stigma around HIV.

The National AIDS Trust are campaigning for an end to prosecutions of reckless transmission of HIV through consensual sex. This is because of the need to affirm the individual’s responsibility for his or her own sexual health; the human rights of those people living with HIV and the difficulties of disclosure; the public health considerations and the potential for further discrimination against people living with HIV and disadvantaged groups such as migrants.

Whilst prosecutions continue, they are working to ensure that the best possible guidance is available to prosecutors, lawyers, police, support organisations, healthcare workers, people living with HIV and the organisations which support them.
Latest information

As a result of pressure from NAT, the Crown Prosecution Service (CPS) carried out a public consultation on its ‘Policy for Prosecuting Cases Involving Sexual Transmission of Infections which causes Grievous Bodily Harm’ in 2006. In 2008 the CPS published new guidance for prosecutors to explain how it deals with cases involving the intentional or reckless transmission of an infection.

The full CPS guidance can be read on the CPS Website.

h3. Police Investigation of HIV Transmission: A guide for people living with HIV in England, Wales and Northern Ireland

The Association of Chief Police Officers (ACPO) published ‘Investigation Guidance Relating to the Criminal Transmission of HIV’.

NAT has produced a leaflet for people living with HIV in England, Wales and Northern Ireland explaining key points of the ACPO Guidance and what to expect and do if you find yourself involved in a police investigation.

Access this document using this link

UPDATE: 08/08/11

Changes have been proposed to legal aid and will remove whole areas from the scheme, leaving many people little choice but to go it alone.  Make sure you know how to represent yourself in court if you ever need to.

Via NAM

Want more? Follow LASSleics on Twitter or subscribe to our blog

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

Detainees ‘denied HIV medication’

Campaign group Medical Justice reported last Tuesday that HIV-positive asylum detainees are being denied live-saving treatment.

It called on the UK Border Agency (UKBA) to end the detention of HIV-positive people after new research showed that most detainees assessed had been denied medication while being held.

More than three-quarters of deported detainees documented had little or no medication, a team of independent doctors found.

On one occasion UKBA attempted to deport an HIV-positive pregnant mother who had been given less than a month’s medication.

Many of the 35 men, women and children assessed are torture survivors from countries where rape is used as a weapon of war.

Medical Justice has been granted permission by the Court of Appeal to intervene in the case of three HIV-positive ex-detainees who argue their detention was unlawful due to a lack of proper treatment.

GP and HIV specialist Dr Indrajit Ghosh said: “UKBA claims that health-care in its centres is equivalent to that in the NHS, but the report shows that being in detention leads to a situation in which these patients cannot access proper medical care.

“In the case of HIV, this is a threat to the patients’ lives. HIV-positive people should therefore be released and properly cared for.”

Cardiff Lib Dem MP Jenny Willott added: “The clinical care in detention centres is currently so poor that it is a dangerous place for someone with HIV. Health and wellbeing is affected and lives are even being shortened. That is unacceptable.”

Director of detention services at UKBA Alan Kittle said it took its duty of care extremely seriously.

“As the Chief Medical Officer has confirmed, decisions regarding treatment and provision of anti-retroviral medication are entirely matters of clinical judgment for the NHS specialist HIV consultants and not UK Border Agency staff or its contractors, including removal centre healthcare providers.

“Individuals are assessed prior to their detention and continue to be treated throughout their stay,” he said.

“On removal, they are provided with a course of the relevant drugs the NHS specialist consultant considers to be necessary.”

Source: http://www.medicaljustice.org.uk/

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

NICE supports expansion of HIV testing at GP’s and in hospital settings

In its first ever guidance related to HIV, the health watchdog NICE recommends that health services not concerned with sexual health take a greater role in offering HIV tests to black African people and to men who have sex with men.

NICE also encourages outreach testing projects for gay men in venues such as saunas and cruising grounds, using rapid point-of-care tests.

The National Institute for Health and Clinical Excellence (NICE) issues recommendations to the NHS about the most effective and cost-effective treatments and public health interventions to provide. In some cases, NHS bodies are legally required to fund medicines and treatments which are recommended by NICE.

Guidelines on HIV testing have been previously issued by organisations representing specialist clinicians such as the British HIV Association (BHIVA) and the British Association for Sexual Health and HIV (BASHH). Their most recent guidelines recommended that HIV testing should be offered to patients in a wide range of healthcare settings, including GP surgeries and most hospital departments.

Implementation of that part of the guidelines has generally been limited, although pilot projects have established that widespread HIV testing is feasible, acceptable to patients and effective in identifying a substantial number of people with undiagnosed HIV.

But with NICE today endorsing large parts of the BHIVA / BASHH guidelines, there may be more hope that non-specialist clinicians will take further steps to promote HIV testing.

NICE have produced public health guidance on increasing the uptake of HIV testing in two related documents.  One concerns interventions for men who have sex with men, the other work with black African communities.

The document concerning black African communities repeats a number of the key recommendations in the BHIVA / BASHH guidelines. In all healthcare settings (including general practice, outpatient and emergency departments), an HIV test should be routinely offered and recommended to all patients who come from high prevalence countries, patients who have had sexual contact abroad and patients who have symptoms that may be related to HIV.

In addition, everybody attending a sexual health, antenatal, termination of pregnancy, drug dependency, tuberculosis, hepatitis B, hepatitis C or lymphoma services should be offered an HIV test.

At health services in areas of relatively high HIV prevalence, healthcare workers ‘should consider’ recommending HIV testing when registering and admitting new patients. In addition, an HIV test should be offered and recommended to all patients who are having another blood test anyway.

Areas of high HIV prevalence are those in which more than two in 1000 have diagnosed HIV. This is the case in most parts of London as well as in places such as Brighton & Hove, Manchester, Blackpool, Salford, Bournemouth and Eastbourne that have historically had high HIV prevalence. Areas which have experienced more recent increases in HIV prevalence such as Luton, Watford, Harlow, Southend-on-Sea, Reading, Slough and Crawley are also included, with around a fifth of the English population living in areas touched by these recommendations.

The wording of the document on testing men who have sex with men is somewhat different, but the implications are similar. In all healthcare settings, male patients who are known to be gay or bisexual should be offered and recommended an HIV test. General practitioners should repeat the offer on an annual basis.

At health services in areas of high HIV prevalence, all male patients (whether they are known to have sex with men or not) should be offered and recommended a test.

For both population groups, NICE recommends that directors of public health and commissioners develop a local strategy for increasing testing rates. The strategy should lead to more health professionals offering HIV testing and more individuals accepting the offer. The strategy should be developed in consultation with local voluntary organisations and community members and should pay particular attention to groups who are less likely to access services.

Community engagement and involvement is seen as particularly important in relation to black African communities. NICE recommends that community members should be recruited and trained to act as champions and role models. Programmes need to address misconceptions about HIV testing and treatment, promote the benefits of early diagnosis and tackle HIV-related stigma.

Health promotion interventions promoting testing to men who have sex with men should be encountered in venues, such as saunas or websites, which facilitate sex between men.

Moreover, the guidance supports outreach testing programmes in high-prevalence areas and also in venues where high-risk sexual behaviour between men occurs. This could include saunas and cruising areas. NICE appears to be more enthusiastic than BHIVA / BASHH about such projects, although they do note that testing will not be appropriate in all such venues. In such settings, rapid tests (using mouth swabs or fingerprick blood samples) should be provided by trained staff, in a secluded or private area.

All testing services (including community testing) need to have clear referral pathways to confirmatory HIV testing, HIV treatment services and support groups. Moreover people who test negative may need referral to counselling and safer sex interventions, as well as repeat testing (for example, if a risk has been taken during a test’s window period). Men who have sex with men are recommended to test annually, or more frequently if their sexual behaviour suggests that they may be at higher risk.

Dr Clare Gerada, chair of the Royal College of General Practitioners commented: “It is important that all health professionals do everything possible to encourage HIV testing amongst high risk groups. The RCGP welcomes the new NICE guidelines and we are sure that GPs will help patients come forward for testing.”

Deborah Jack, Chief Executive of NAT (National AIDS Trust) said: “It is crucial that HIV testing becomes ‘normalised’ in our society, not just among gay men and African communities, but also amongst health professionals. Many people with HIV attend NHS services for years without being offered an HIV test and this neglect needs to be addressed and stopped.” She called for late HIV diagnosis to be used a key outcome indicator in public health monitoring and for the new government body, Public Health England, to ensure that NICE’s recommendations are “consistently implemented across the whole of the NHS and public health system”.

Source: http://www.aidsmap.com/NICE-supports-expansion-of-HIV-testing-at-GPs-and-in-hospital-settings/page/1735227/

LASS offer a completly free and confidential rapid HIV test and you’ll get the results within 60 seconds from a simple finger prick test.  We use the Insti HIV test produced by BioLytical laboratories.  The test is 99.96% accurate from 90 days post contact for detecting HIV 1 and 2 antibodies.

Appointments are not always necessary, if you would like a test, please contact us on 0116 2559995

STAY UPDATED
Follow LASS on Twitter
or subscribe via email

Get free access to online services, tools and community spaces for everyone living with HIV in the UK.

 

The Secretary of State for Health, The Rt Hon Andrew Lansley MP, and the Terrence Higgins Trust have launched a new resource, Life Plus, which will transform the way people with HIV manage their condition long term. Created by the Elton John AIDS Foundation (EJAF), HIV and sexual health charity Terrence Higgins Trust (THT) and people with HIV, Life Plus is an innovative set of online, face to face and telephone support services that delivers cost effective, personalised support for people living with HIV in the UK.

Andrew Lansley met service users at the Harrison Wing, Guy’s and St Thomas’ Hospital, London to find out first-hand the impact that Life Plus will have. St Thomas’ is situated in South London, which has the highest prevalence of HIV in the UK, and is a leading hospital for HIV care

Currently around 86,500 people are living with HIV in the UK, and every year around 7,000 more are diagnosed. This creates mounting pressure on an already constrained NHS. Life Plus, funded by the Elton John AIDS Foundation and developed in partnership with HIV organisations George House Trust and National AIDS Manual (NAM), is designed to ease this pressure by offering vital free support to help people with HIV live long and healthy lives, whilst relieving clinical expertise to wholly focus where it is most needed.

Life Plus will partner NHS clinical care by providing face to face support in areas of the UK which have high rates of HIV prevalence; Brighton, Birmingham, Glasgow, Cardiff and Manchester. Clinic-based Health Trainers in each of these cities will provide people living with HIV with one-to-one support, to become experts in managing their condition and the social care challenges that may jeopardise their health and medical treatment.

As part of the programme, a dedicated new website, www.myhiv.org.uk, will also enable people living with HIV to access interactive services tailored to their individual needs, requirements and stage of diagnosis, wherever they live in the UK, including:

· The option to privately and securely store information on their health and treatment so they can monitor and actively manage their HIV and stay adherent to treatment

· A reminder function for clinic appointments

· Forums for people to build communities and offer support to each other

· Online counselling and advice

· Information on how to become an active campaigner on HIV issues

For people who don’t have access to the internet at home, THT is working with HIV clinics, including the Harrison Wing at St Thomas’ Hospital in London, to offer free internet access to www.myhiv.org.uk and video conferencing facilities so that people can talk to experts from THT in clinics. People can also access confidential support from the charity’s helpline, THT Direct, on 0845 12 21 200.

Sir Nick Partridge, Chief Executive for Terrence Higgins Trust said: “Life Plus is a very exciting new type of service provision and comes at a critical time to support the higher numbers of people living with HIV in the UK. HIV is a complex condition so it’s vital that people get the best possible level of support, accessible in a multitude of ways, to ensure they remain healthy.

“HIV service providers and clinicians across the country have been fundamental in shaping Life Plus and these services have been designed to reach people in both rural and urban areas, whether they’re newly diagnosed or have been living with HIV for many years. Thanks to the Elton John AIDS Foundation these services will revolutionise support for people with HIV, helping them to manage their health and treatment more effectively.”

Sir Elton John, Founder of the Elton John AIDS Foundation said: “In many ways, the UK response to prevention and treatment of HIV has led the world. I am proud to be launching a new era in HIV services, delighted to be working with THT again, and hopeful that this approach may see opportunities for the management of other long term chronic conditions.”

If you have any questions or comments, please contact them at: membership www.tht.org.uk/membership

STAY UPDATED
Follow LASS on Twitter
or subscribe via email